Data month 2026-08
Evozyne, Inc.evozyne.comDesigns therapeutic proteins with generative AI, focused on immune-mediated diseases.
According to AlphaMoat, in 2026-08 Evozyne (evozyne.com) received 2,832 monthly visits (+5.3% MoM) — ranked #14,220 of 17,407 AI websites with traffic data, and #832 of 1,026 in Education & Research; its largest market is United States (100.0% of visits).
Monthly Visits · 2026-08
2.8K+5.3%
Overall Rank (17,407)
#14,220
Education & Research Rank (1,026)
#832
Top Market
United States100.0%
What is Evozyne
Product Overview
Evozyne uses generative artificial intelligence to design novel therapeutic proteins for patient needs in immune-mediated diseases unmet by existing biologics and small molecules, positioning itself as an AI-native protein-design company.
Key Features2 items
- 01Its AI engine EvoGen learns the relationship between protein sequence and function and designs candidate proteins by potency, stability, specificity, and immunogenicity, then the high-throughput experimental facility EvoLab performs synthesis and evaluation
- 02the company was founded by Paragon Biosciences
12-Month Traffic Trend
Hover for monthly values
Latest 2.8KMoM+5.3%
2026-06
5.0K
—
2026-07
2.7K
-45.9%
2026-08
2.8K
+5.3%
Visits by Country · Top 5
2026-08 · Share of total visits
United States
2,832100.0%
Popular in Education & Research
Click for details, or "+ Compare" to compare with Evozyne
Data month: 2026-08 · Visit figures are third-party traffic estimates aggregated monthly — best for scale and trends. Multiple domains of the same product are merged. See methodology.